Details for New Drug Application (NDA): 019886
✉ Email this page to a colleague
The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.
Summary for 019886
Tradename: | SYNAREL |
Applicant: | Pfizer |
Ingredient: | nafarelin acetate |
Patents: | 0 |
Pharmacology for NDA: 019886
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 019886
Suppliers and Packaging for NDA: 019886
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-0166 | 0025-0166-08 | 1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) / 8 mL in 1 BOTTLE, SPRAY |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | EQ 0.2MG BASE/SPRAY | ||||
Approval Date: | Feb 13, 1990 | TE: | RLD: | Yes |
Expired US Patents for NDA 019886
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription